LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.
Rachunek Zysków i Strat
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
Rok finansowy |
2021 |
2021 |
2022 |
2022 |
2023 |
2023 |
2024 |
2024 |
Kwartał |
Q2 |
Q4 |
Q2 |
Q4 |
Q2 |
Q4 |
Q2 |
Q4 |
Data |
2021-06-30 |
2021-12-31 |
2022-06-30 |
2022-12-31 |
2023-06-30 |
2023-12-31 |
2024-06-30 |
2024-12-31 |
Przychód (mln) |
111 |
112 |
125 |
123 |
166 |
160 |
249 |
223 |
Przychód Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
49.5% |
43.3% |
99.6% |
81.1% |
Marża brutto |
89.3% |
88.2% |
87.7% |
89.7% |
88.9% |
88.3% |
91.0% |
88.7% |
Koszty i Wydatki (mln) |
65 |
88 |
95 |
154 |
90 |
78 |
85 |
100 |
EBIT (mln) |
63 |
33 |
57 |
49 |
79 |
86 |
164 |
122 |
EBIT Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
25.0% |
162.8% |
187.7% |
149.4% |
EBIT (%) |
56.9% |
29.2% |
45.6% |
39.9% |
47.6% |
53.6% |
65.8% |
54.9% |
Przychody fiansowe (mln) |
1 |
3 |
4 |
9 |
11 |
3 |
0 |
22 |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Amortyzacja (mln) |
3 |
5 |
6 |
6 |
7 |
7 |
9 |
-7 |
EBITDA (mln) |
67 |
37 |
63 |
55 |
85 |
92 |
155 |
133 |
EBITDA(%) |
59.9% |
33.5% |
50.1% |
45.1% |
51.5% |
57.8% |
62.1% |
59.9% |
NOPLAT (mln) |
45 |
21 |
25 |
-40 |
88 |
86 |
164 |
122 |
Podatek (mln) |
3 |
4 |
1 |
4 |
12 |
10 |
24 |
17 |
Zysk Netto (mln) |
42 |
17 |
24 |
-44 |
76 |
75 |
140 |
105 |
Zysk netto Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
82.2% |
345.6% |
478.1% |
339.0% |
Zysk netto (%) |
37.6% |
15.2% |
19.4% |
-35.87% |
45.9% |
47.2% |
56.3% |
47.3% |
EPS |
0.15 |
0.0522 |
0.0748 |
-0.13 |
0.22 |
0.22 |
0.4 |
0.31 |
EPS (rozwodnione) |
0.15 |
0.0522 |
0.0748 |
-0.13 |
0.22 |
0.22 |
0.4 |
0.31 |
Ilośc akcji (mln) |
283 |
325 |
324 |
331 |
347 |
347 |
347 |
347 |
Ważona ilośc akcji (mln) |
283 |
325 |
324 |
331 |
347 |
347 |
347 |
347 |
Waluta |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |